30 results - M - W - D

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
5/25/06 19:24
5/25/06
RNAIHealthDrugPharmaceutical PreparationsWeaver Gregory LCAOSVP,CFOP765.06015New15
7/8/05 19:06
7/6/05
RNAIHealthDrugPharmaceutical PreparationsGreer R ScottCADP.d601.6003854107D
7/8/05 17:47
7/6/05
RNAIHealthDrugPharmaceutical PreparationsCredit Suisse/NYTP.d4,8751.6003,0472614,872I
7/8/05 16:51
7/6/05
RNAIHealthDrugPharmaceutical PreparationsOxford Bioscience Partners IV LPMATP.d2,0001.6001,250275,865M
7/8/05 16:40
7/6/05
RNAIHealthDrugPharmaceutical PreparationsNiedel JamesNYDTP.d5,0001.6003,1252615,253M
7/8/05 11:07
7/6/05
RNAIHealthDrugPharmaceutical PreparationsRoberts Bryan ECADTP.d2,0001.6001,250151I
7/8/05 11:06
7/6/05
RNAIHealthDrugPharmaceutical PreparationsVef Management III LLCNYTP.d401.6002520151I
7/8/05 11:04
7/6/05
RNAIHealthDrugPharmaceutical PreparationsVenrock Management III LLCNYTP.d1,6001.6001,000206,039I
7/8/05 11:02
7/6/05
RNAIHealthDrugPharmaceutical PreparationsVenrock Entrepreneurs Fund III LPNYTP.d401.6002520151D
7/8/05 11:01
7/6/05
RNAIHealthDrugPharmaceutical PreparationsVenrock Associates III LPNYTP.d1,6001.6001,000206,039D
7/8/05 10:59
7/6/05
RNAIHealthDrugPharmaceutical PreparationsVenrock AssociatesNYTP.d3601.600225201,359D
12/10/03 21:21
12/9/03
RNAIHealthDrugPharmaceutical PreparationsMrna Fund II LPMATS-46.000-103,797M
12/10/03 21:16
12/9/03
RNAIHealthDrugPharmaceutical PreparationsOxford Bioscience Partners IV LPMATS-46.000-103,797M
12/1/03 15:08
11/26/03
RNAIHealthDrugPharmaceutical PreparationsMrna Fund II LPMATS-246.000-402,798M
12/1/03 15:06
11/26/03
RNAIHealthDrugPharmaceutical PreparationsOxford Bioscience Partners IV LPMATS-246.000-403,798M
11/26/03 15:22
11/25/03
RNAIHealthDrugPharmaceutical PreparationsOxford Bioscience Partners IV LPMATS-276.030-503,802M
11/26/03 15:19
11/25/03
RNAIHealthDrugPharmaceutical PreparationsMrna Fund II LPMATS-276.030-503,802M
11/21/03 14:16
11/20/03
RNAIHealthDrugPharmaceutical PreparationsOxford Bioscience Partners IV LPMATS-36.060-103,806M
11/21/03 14:13
11/20/03
RNAIHealthDrugPharmaceutical PreparationsMrna Fund II LPMATS-36.060-103,806M
11/20/03 16:09
11/18/03
RNAIHealthDrugPharmaceutical PreparationsMrna Fund II LPMATS-506.210-803,807M
11/20/03 16:04
11/18/03
RNAIHealthDrugPharmaceutical PreparationsOxford Bioscience Partners IV LPMATS-506.210-803,807M
11/18/03 18:17
11/14/03
RNAIHealthDrugPharmaceutical PreparationsOxford Bioscience Partners IV LPMATS.m-2736.210-44-13,815M
11/18/03 18:15
11/14/03
RNAIHealthDrugPharmaceutical PreparationsMrna Fund II LPMATS.m-2736.210-44-13,815M
11/14/03 18:33
11/12/03
RNAIHealthDrugPharmaceutical PreparationsMrna Fund II LPMATS.m-1546.680-23-13,863M
11/14/03 18:32
11/12/03
RNAIHealthDrugPharmaceutical PreparationsOxford Bioscience Partners IV LPMATS.m-1546.680-23-13,863M
11/13/03 19:03
11/10/03
RNAIHealthDrugPharmaceutical PreparationsMrna Fund II LPMATS-16.8300039D
11/13/03 18:37
11/6/03
RNAIHealthDrugPharmaceutical PreparationsMrna Fund II LPMATS.m-47.080-1-239D
11/12/03 13:29
11/10/03
RNAIHealthDrugPharmaceutical PreparationsOxford Bioscience Partners IV LPMATS-816.830-1203,843D
11/10/03 21:09
11/6/03
RNAIHealthDrugPharmaceutical PreparationsOxford Bioscience Partners IV LPMATS.m-4397.080-62-23,855D
8/14/03 21:30
8/12/03
RNAIHealthDrugPharmaceutical PreparationsGreer R ScottCODM1713.41050999%55D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact